Eastern Bank Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Eastern Bank boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,266 shares of the medical equipment provider’s stock after buying an additional 203 shares during the period. Eastern Bank’s holdings in Intuitive Surgical were worth $2,227,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Claro Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.1% during the fourth quarter. Claro Advisors LLC now owns 1,250 shares of the medical equipment provider’s stock valued at $652,000 after acquiring an additional 37 shares in the last quarter. Cooper Financial Group grew its position in Intuitive Surgical by 23.4% during the 4th quarter. Cooper Financial Group now owns 1,059 shares of the medical equipment provider’s stock valued at $553,000 after purchasing an additional 201 shares during the last quarter. Wedmont Private Capital increased its stake in Intuitive Surgical by 7.6% during the 4th quarter. Wedmont Private Capital now owns 6,102 shares of the medical equipment provider’s stock valued at $3,341,000 after purchasing an additional 431 shares in the last quarter. Fragasso Financial Advisors Inc raised its holdings in Intuitive Surgical by 3.0% in the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 20 shares during the last quarter. Finally, Kieckhefer Group LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $5,632,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $539.75 on Tuesday. The stock has a market cap of $192.25 billion, a P/E ratio of 86.78, a P/E/G ratio of 5.31 and a beta of 1.39. The stock’s fifty day moving average is $536.58 and its 200 day moving average is $495.83. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 over the last three months. 0.90% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ISRG. Truist Financial boosted their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup raised their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.